Real-time enrollment status for this primary membranous nephropathy clinical trial
Current Status
Active, Not Recruiting
Checked: March 2, 2026 at 10:32 AM UTC
| NCT Number | NCT05707377 |
| Recruiting Status | Active, Not Recruiting |
| Condition | Primary Membranous Nephropathy |
| Phase | Clinical Trial |
| Target Enrollment | 282 participants |
| Active Locations | 9 sites in the US |
| Sponsor | BeiGene |
| Last Updated on CT.gov | February 23, 2026 (1 week ago) |
As of March 2, 2026: Clinical trial NCT05707377 is currently active_not_recruiting participants. This clinical trial study for primary membranous nephropathy is not currently accepting new participants at 9 locations across the United States. The study is sponsored by BeiGene. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT05707377 is currently active_not_recruiting. The study may resume recruiting in the future.
This trial is recruiting at 9 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05707377 was last updated 1 week ago (February 23, 2026). HelloStudys verifies this status automatically.